These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25037561)

  • 1. Protein carbamylation in kidney disease: pathogenesis and clinical implications.
    Kalim S; Karumanchi SA; Thadhani RI; Berg AH
    Am J Kidney Dis; 2014 Nov; 64(5):793-803. PubMed ID: 25037561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Carbamylation in Chronic Kidney Disease and Dialysis.
    Long J; Vela Parada X; Kalim S
    Adv Clin Chem; 2018; 87():37-67. PubMed ID: 30342712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Carbamylated Biomolecules in Human Diseases.
    Badar A; Arif Z; Alam K
    IUBMB Life; 2018 Apr; 70(4):267-275. PubMed ID: 29542227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis.
    Jaisson S; Pietrement C; Gillery P
    Clin Chem; 2011 Nov; 57(11):1499-505. PubMed ID: 21768218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein carbamylation in end stage renal disease: is there a mortality effect?
    Kalim S
    Curr Opin Nephrol Hypertens; 2018 Nov; 27(6):454-462. PubMed ID: 30148723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease].
    Mikhailova NA
    Ter Arkh; 2021 Jun; 93(6):729-735. PubMed ID: 36286841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Carbamylation and the Risk of ESKD in Patients with CKD.
    Kalim S; Zhao S; Tang M; Rhee EP; Allegretti AS; Nigwekar S; Karumanchi SA; Lash JP; Berg AH
    J Am Soc Nephrol; 2023 May; 34(5):876-885. PubMed ID: 36757153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamylated Proteins in Renal Disease: Aggravating Factors or Just Biomarkers?
    Gorisse L; Jaisson S; Piétrement C; Gillery P
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis.
    Kalim S; Trottier CA; Wenger JB; Wibecan J; Ahmed R; Ankers E; Karumanchi SA; Thadhani R; Berg AH
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1809-1816. PubMed ID: 27445162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carbamylation of proteins--mechanism, causes and consequences].
    Pieniążek A; Gwoździński K
    Postepy Hig Med Dosw (Online); 2016 May; 70():514-21. PubMed ID: 27180968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies.
    Shi J; van Veelen PA; Mahler M; Janssen GM; Drijfhout JW; Huizinga TW; Toes RE; Trouw LA
    Autoimmun Rev; 2014 Mar; 13(3):225-30. PubMed ID: 24176675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamylation of proteins and sulfacetamide free fraction in serum in experimentally-induced high blood urea states.
    Erill S; du Souich P; Courteau H
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):45-56. PubMed ID: 4081313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired biological activity of erythropoietin by cyanate carbamylation.
    Mun KC; Golper TA
    Blood Purif; 2000; 18(1):13-7. PubMed ID: 10686438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein carbamylation links inflammation, smoking, uremia and atherogenesis.
    Wang Z; Nicholls SJ; Rodriguez ER; Kummu O; Hörkkö S; Barnard J; Reynolds WF; Topol EJ; DiDonato JA; Hazen SL
    Nat Med; 2007 Oct; 13(10):1176-84. PubMed ID: 17828273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure.
    Berg AH; Drechsler C; Wenger J; Buccafusca R; Hod T; Kalim S; Ramma W; Parikh SM; Steen H; Friedman DJ; Danziger J; Wanner C; Thadhani R; Karumanchi SA
    Sci Transl Med; 2013 Mar; 5(175):175ra29. PubMed ID: 23467560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study.
    Kalim S; Berg AH; Karumanchi SA; Thadhani R; Allegretti AS; Nigwekar S; Zhao S; Srivastava A; Raj D; Deo R; Frydrych A; Chen J; Sondheimer J; Shafi T; Weir M; Lash JP;
    Nephrol Dial Transplant; 2021 Dec; 37(1):139-147. PubMed ID: 33661286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease.
    Kalim S; Tamez H; Wenger J; Ankers E; Trottier CA; Deferio JJ; Berg AH; Karumanchi SA; Thadhani RI
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1927-34. PubMed ID: 23970130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamylation of Integrin
    Binder V; Chruścicka-Smaga B; Bergum B; Jaisson S; Gillery P; Sivertsen J; Hervig T; Kaminska M; Tilvawala R; Nemmara VV; Thompson PR; Potempa J; Marti HP; Mydel P
    J Am Soc Nephrol; 2022 Oct; 33(10):1841-1856. PubMed ID: 36038265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamoylation of amino acids and proteins in uremia.
    Kraus LM; Kraus AP
    Kidney Int Suppl; 2001 Feb; 78():S102-7. PubMed ID: 11168993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamylation is a competitor of glycation for protein modification in vivo.
    Nicolas C; Jaisson S; Gorisse L; Tessier FJ; Niquet-Léridon C; Jacolot P; Pietrement C; Gillery P
    Diabetes Metab; 2018 Mar; 44(2):160-167. PubMed ID: 28690125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.